These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2423678

  • 1. [125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1986 May; 38(5):406-8. PubMed ID: 2423678
    [Abstract] [Full Text] [Related]

  • 2. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
    [Abstract] [Full Text] [Related]

  • 3. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
    [Abstract] [Full Text] [Related]

  • 4. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 5. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL, Largent BL, Snyder SH.
    Life Sci; 1984 Nov 05; 35(19):1981-8. PubMed ID: 6149442
    [Abstract] [Full Text] [Related]

  • 6. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec 05; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 7. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
    Weller ME, Rose S, Jenner P, Marsden CD.
    Neuropharmacology; 1987 Apr 05; 26(4):347-54. PubMed ID: 2438586
    [Abstract] [Full Text] [Related]

  • 8. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H, Wedel I.
    Acta Pharmacol Toxicol (Copenh); 1986 May 05; 58(5):368-73. PubMed ID: 2943136
    [Abstract] [Full Text] [Related]

  • 9. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ, Jenner P, Marsden CD.
    Eur J Pharmacol; 1984 Dec 15; 107(1):71-8. PubMed ID: 6084599
    [Abstract] [Full Text] [Related]

  • 10. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K, Nomura Y.
    Dev Neurosci; 1982 Dec 15; 5(4):379-84. PubMed ID: 7140585
    [Abstract] [Full Text] [Related]

  • 11. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan 15; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

  • 12. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S, Coward D.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb 15; 335(2):115-22. PubMed ID: 2951601
    [Abstract] [Full Text] [Related]

  • 13. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2973-7. PubMed ID: 6626267
    [Abstract] [Full Text] [Related]

  • 14. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
    Theodorou AE, Hall MD, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1980 Jun 01; 32(6):441-4. PubMed ID: 6106685
    [No Abstract] [Full Text] [Related]

  • 15. Ontogenetic development of the striatal [3H]spiperone binding: regulation by sodium and guanine nucleotide in rats.
    Nomura Y, Oki K, Segawa T.
    J Neurochem; 1982 Apr 01; 38(4):902-8. PubMed ID: 6174692
    [Abstract] [Full Text] [Related]

  • 16. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 01; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 17. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 01; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 18. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M, Vrsecká M, Krejcí I, Dlabac A.
    Eur J Pharmacol; 1987 Apr 07; 136(1):97-101. PubMed ID: 3297739
    [Abstract] [Full Text] [Related]

  • 19. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain.
    Gundlach AL, McDonald D, Beart PM.
    J Neurochem; 1982 Sep 07; 39(3):890-4. PubMed ID: 7097294
    [Abstract] [Full Text] [Related]

  • 20. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF.
    Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.